the history of dengue research before 1950 a forgotten history
Download
Skip this Video
Download Presentation
The History of Dengue Research before 1950 A Forgotten History ?

Loading in 2 Seconds...

play fullscreen
1 / 83

The History of Dengue Research before 1950 A Forgotten History - PowerPoint PPT Presentation


  • 224 Views
  • Uploaded on

The History of Dengue Research before 1950 A Forgotten History ?. Early Dengue Investigation in the Shadow of Yellow Fever Research. Reminder “Dengue”=dengue or dengue-like illness Period covered: 1890-1950. Important Events: 1897-98. 1. “Filterable agent” [=virus]

loader
I am the owner, or an agent authorized to act on behalf of the owner, of the copyrighted work described.
capcha
Download Presentation

PowerPoint Slideshow about 'The History of Dengue Research before 1950 A Forgotten History ' - bernad


An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -
Presentation Transcript
important events 1897 98
Important Events: 1897-98

1. “Filterable agent” [=virus]

2. Vector-borne transmission

3. Extrinsic incubation period

4. Controversy on etiology of YF

5. Dengue outbreaks in Texas

6. Spanish-American War

slide7
Walter Reed

(Source: U.S. Army Archive)

slide8
Farewell Clara….Clara was buried in Havana, Cuba and later reburied in New Jersey at Fairmount Cemetery

.

slide9
Charles Franklin Craig

(Source: Am. J. Trop. Med., 1951)

slide13
Carlos Juan Finlay

(Source: Univ. Virginia Claude Moore Health Science Library)

photo

Photo

Henry Rose Carter

(Source: Am. J. Publ. Hlth. 15:994; 1926)

experimental design for dengue transmission studies

Experimental Design for Dengue Transmission Studies

Source of

“infectious agent”

2. Location for human

experiment

special considerations for human experiment
Special Considerations for Human Experiment
  • Informed Consent
  • Monetary Reward
slide19
Harris Graham

(Source: American University of Beirut, Lebanon)

slide20

Dengue Studies in Cubaby the Former Members of the Walter Reed Commission: Left—Aristides Agramonte; Right– Juan Guiteras (Source of photos: Wikipedia Commons)

t l bancroft source courtesy of australian nat univ
T.L. Bancroft

(Source: Courtesy of Australian Nat. Univ.)

slide23
Makoto Koizumi(Source: The 50-year history (1929-79) of parasitologic research in Japan. Japanese Society of Parasitologists, 1981)
slide24
J. Burton Cleland

(Source: Courtesy: Australian National

University)

slide26
James S. Simmons

(Source: U.S. Army Archive)

slide27
Emilius Paulus Snijders

(Source: Academic Medical Centre, University of Amsterdam, The Netherlands)

slide28
Dutch group portrait by Lizzy Ansingh (1933): From left to right-van Loghem, Kuenen, Schueffner, Swellengrebel, Snijders (Source: Univ. Museum Amsterdam)
slide30
Susumu Hotta

(Source: Kobe University School of Medicine,

Kobe, Japan)

slide31
Mrs. Mochizuki

(Source: S. Hotta-- Uirusu, 51:106; 2001)

albert b sabin courtesy u s army
Albert B. Sabin

(Courtesy: U.S. Army )

slide33
Sabin visiting Hotta at Kobe University, 1961

(Source: Kobe University, Kobe, Japan)

slide34
Cornelius Becker Philip

(Source: J. Parasitol. 73:678)

laboratory identified dengue viruses
Laboratory-identified DengueViruses

Year Location Serotype

  • Nagasaki, Japan DENV-1

1943-44 Hawaii DENV-1

  • New Guinea DENV-1 and

DENV-2

serologically identified viruses
Serologically-identified Viruses

1924-25 Philippines DENV-4

1925-26 QLD, Australia DENV-1

  • South Africa DENV-1

1929-30 Philippines DENV-1

  • QLD, Australia DENV-2/DENV-1
  • Singapore DENV-1

1944-45 Guam DENV-2(DENV-1?)

  • Calcutta, India DENV-1

1942-44 Japan DENV-1(DENV-2?)

clinical definition of dengue a source of constant controversy
Clinical Definition of “Dengue”- a Source of Constant Controversy
  • Variation depending on physicians, year, location, and unknown human conditions

2. “Typical” vs “atypical” symptoms

3. Syndrome in human experiment

as ‘standard”

4. Confusion with other etiologies

slide39
F. E. Hare

(Source: J. Aaskov, Austr. Defense Force Health 4:66;2003)

hemorrhagic manifestations and fatality
Hemorrhagic Manifestations and Fatality

Diagnosis:

Rumpell-Leede test (=Tourniquet test)

Borbely’s vascular resistance test

Study:

Correlations among increased vascular permeability, thrombocytopenia, and hemorrhage

selected records of fatal cases

Selected Records of Fatal Cases

1895-1926 Australia 816

QLD, Australia 97

1904-05 Australia 201

Australia 93

1907-09 Vietnam 4

Okinawa, Japan 508

Taiwan 26

1943-44 Philippines 7

Taiwan 5

slide43

Fatal

Non-Fatal

[A] 1897 - 1902

[B] 1926 - 1931

[C] 1940 - 1944

medical care

Medical Care

Antipyretics

Salicylates (Aspirin-contraindicant)

Immunotherapy

Blood transfusion

slide48
The Importance of Human Movement by Ships andthe Critical Roles played by the Physicians on board for unraveling Dengue Transmission
slide53
Mapping New Cases in Chronologic Order

(Source: Miyao,T. Kaigun-Gun-Ikai-Zasshi 20:564;1931)

slide54
Recognition of dengue as an urban disease

(Source: Barraud, P.J. Indian J. Med. Res. 16:377; 1928)

slide56
Transmission in a Military Barrack

(Source: Kennedy, R.S. Indian Med. Gaz. 46:436; 1912)

dengue attack difference indoor vs outdoor source clayton f h a j roy army med corps 14 171 1910
Dengue Attack Difference—Indoor vs Outdoor(Source: Clayton,F.H.A. J. Roy. Army Med. Corps 14:171;1910)
epidemiologic reporting

Epidemiologic Reporting

Dengue as a reportable disease

Western Australia—1912

International Sanitary

Convention--1934

multiple dengue infection

Multiple Dengue Infection

1. Occurrence

2. Interpretation

a. Dengue-multiple etiologies

b. Opposition to vaccine development

3. Emergence of the concept of “multiple

immunotype”

4. Existence of 4 serotypes

slide63
Antibody response profiles—primary (lower curve) vs re-infection (upper curve)

(Source: Hotta, S & Kimura, R. Nisshin Igaku 36:470;1949)

development of serologic tests
Development of Serologic Tests

A. Complement Fixation Test (CF)

Earlier application for YF since 1929

Application to dengue by Sabin- 1948

B. Neutralization (in vivo) Test (NT)

Development for YF since 1929

Sawyer and Lloyd—1931

Application to dengue in the 1940s

animal model
Animal Model

Vertebrates other than primates

Unique breed of Swiss (albino) mouse

“dba” =dilute brown non-agouti

Subhuman primates

Macaca fasciatus

Macaca philippinensis

vector identification and biology

Vector Identification and Biology

Vectors:

Aedes aegypti -- T. Bancroft

Ae. albopictus– M. Koizumi

Ae. scutellaris – R.H. Daggy

Breeding technique:

Ae. aegypti – J. Siler

geographic distribution of vectors
Geographic Distribution of Vectors

Aedes aegypti and Ae. albopictus

H. Kumm – 1931

Clara Ludlow

slide68
Clara S. Ludlow

(Source: George Washington University Photographic Collection)

venereal and vertical transmission in mosquitoes
Venereal and Vertical Transmission in Mosquitoes

Venereal Transmission

Simmons, et al. (1931)

Vertical Transmission

Impacts of earlier YF studies by

Simond and Marchoux

For dengue

Legendre (1911) and Siler, et al. (1925)

slide70
Jean-Paul Simond

(Courtesy: Thomas P. Monath)

slide71
Emile Marchoux

(Courtesy: Thomas P. Monath)

vector control biological control

Vector Control:Biological Control:

Predatory mosquitoes

(Toxorhynchites spp.)

2. Fishes

slide74
Toxorhynchites Larva(Source: New South Wales Arbovirus Surveillance and Vector Monitoring Programme, Australia)
slide75
Kill fish (Oryzias latipes)

(Source: http://biol1.bio.nagoya-

u.ac.jp:8000/9808/8.html)

vector control

Vector Control

Applications of Insecticides

Including Indoor Residual Spray of DDT

vector control77
Vector Control
  • Source reduction
  • Community participation
  • Public education and organized campaign
dengue prevention other than vector control
Dengue Prevention other than Vector Control

Unusual people’s reaction to fear

International Convention

League of Nations

Legislation of Law

vaccine development attenuation or inactivation methods

Vaccine Development- attenuation or inactivation methods

Cleland (1917-19) – human passage

Blanc & Caminopetros (1931)– bovine bile

St. John & Holt (1931) – killed vaccine

Holt, et al. (1931) – X-ray irradiation

Simmons, et al. (1929-31) – mosquito passage

+ antiserum + desiccation

Hotta & Kimura (1943-49) – formalin

Sabin & Schlesinger (1944-49) –attenuation in

suckling mice

slide81

Economic Cost Estimate[reproduced with minor modifications] (Source: Hamlyn-Smith, R. Ann. Trop. Med. Parasitol. 25:21;1931)

Occupation Loss in wage (pound/ % Sick Workers

Category shilling/d)

1 438/4/8 65.6

2 569/2/7 23.8

3 213/17/4 17.0

4 200/0/0 20.0

5 220/0/0 20.0

6 303/0/0 26.0

7 500/0/0 35.0

8 130/0/0 24.0

9 1451/0/0 15.3

slide82

Completing the full Circle of YF and Dengue Research History Interaction: Grave Sites of Walter Reed and Albert Sabin(Arlington National Cemetery, Virginia)(Source: U.S. National Archives)

acknowledgments
Acknowledgments

Yuki Eshita- Oita University School of Medicine, Oita, Japan

David Hill – U.S. Army, Silver Spring, Maryland, USA

Eva Lee – Australian National University, Canberra, ACT, Australia

Jennifer Lehman – CDC, Fort Collins, Colorado, USA

Mathieu Mazarin – CDC, Fort Collins, Colorado, USA

Thomas P. Monath – Kleisner Perkins Caufield & Byers, Menlo Park, California, USA

J.F. Wendte – Medical Centre, University of Amsterdam, the Netherlands

ad